OpenAI CEO Sam Altman called Stargate, “the most important project for this era” and promised that all of the new investment his company was making would help cure diseases. Altman was actually prompted by Trump to talk about the medical advances that AI would supposedly figure out.
The Stargate project has big implications for U.S. AI leadership, but also for who's winning the new president's ear.
Musk slammed a Trump-backed $500 billion AI joint venture building out OpenAI’s artificial general intelligence.
The president said he’s also open to another tech giant to acquire TikTok: Larry Ellison, co-founder of Oracle. Ellison was present at the White House for a $500 billion AI infrastructure partnership between the Trump administration and OpenAI, Softbank and Oracle. Oracle, a software company, houses most of TikTok's servers
The $500 billion Stargate artificial intelligence project was officially announced by President Donald Trump at a press conference yesterday. Standing
Trump announced Tuesday that OpenAI, Softbank and Oracle would join forces to create Stargate, a new company investing $500 billion in AI infrastructure.
President Donald Trump talked up a joint venture investing up to $500 billion for infrastructure tied to AI by a new partnership formed by OpenAI, Oracle and SoftBank.
President Donald Trump stood with one of San Francisco’s top tech tycoons inside the White House on Tuesday to announce a $500 billion artificial intelligence project, dubbed “Stargate.” Trump held a press conference alongside Sam Altman of OpenAI and Larry Ellison of Oracle to reveal to hefty investments for creating infrastructure to power
Larry Ellison, the co-founder of Oracle and the company's chief technological officer (CTO), saw his total net worth surge by a staggering USD 12.3 billion or Rs 1,06,470 crore, close to 6.3 per cent, in no time.
President Donald Trump spoke with OpenAI CEO Sam Altman by phone on Friday, ahead of the AI infrastructure announcement, CNBC has learned.
Chairman Larry Ellison highlighted the AI's potential in the development of mRNA-based cancer vaccines. Read more here.